BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29976651)

  • 1. Burden and risk factors for
    Restrepo MI; Babu BL; Reyes LF; Chalmers JD; Soni NJ; Sibila O; Faverio P; Cilloniz C; Rodriguez-Cintron W; Aliberti S;
    Eur Respir J; 2018 Aug; 52(2):. PubMed ID: 29976651
    [No Abstract]   [Full Text] [Related]  

  • 2. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis.
    Ding C; Yang Z; Wang J; Liu X; Cao Y; Pan Y; Han L; Zhan S
    Int J Infect Dis; 2016 Aug; 49():119-28. PubMed ID: 27329135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia.
    Aliberti S; Cook GS; Babu BL; Reyes LF; H Rodriguez A; Sanz F; Soni NJ; Anzueto A; Faverio P; Sadud RF; Muhammad I; Prat C; Vendrell E; Neves J; Kaimakamis E; Feneley A; Swarnakar R; Franzetti F; Carugati M; Morosi M; Monge E; Restrepo MI;
    J Infect; 2019 Oct; 79(4):300-311. PubMed ID: 31299410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on the composition and antibiotic-resistance of pathogenic bacteria between children with community-acquired and hospital-acquired pneumonia].
    Wang Z; Ji W; Guo HB; Tao YZ; Ding YF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):211-6. PubMed ID: 21624231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia.
    Sibila O; Laserna E; Maselli DJ; Fernandez JF; Mortensen EM; Anzueto A; Waterer G; Restrepo MI
    Respirology; 2015 May; 20(4):660-6. PubMed ID: 25776134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis.
    Arancibia F; Bauer TT; Ewig S; Mensa J; Gonzalez J; Niederman MS; Torres A
    Arch Intern Med; 2002 Sep; 162(16):1849-58. PubMed ID: 12196083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department.
    Angrill N; Gallego M; Font J; Vallés J; Morón A; Monsó E; Rello J
    BMC Pulm Med; 2020 Apr; 20(1):83. PubMed ID: 32245452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictors of drug-resistant pathogens in community-onset pneumonia: Are factors considered in health-care-associated pneumonia useful in the emergency department?].
    Torres Bonafonte OH; Gil Olivas E; Pérez Macho E; Pacho Pacho C; Mateo Roca M; Casademont Pou J; Ruiz Hidalgo D
    Emergencias; 2017 Oct; 29(5):306-312. PubMed ID: 29077289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.
    Wu CL; Ku SC; Yang KY; Fang WF; Tu CY; Chen CW; Hsu KH; Fan WC; Lin MC; Chen W; Ou CY; Yu CJ
    J Formos Med Assoc; 2013 Jan; 112(1):31-40. PubMed ID: 23332427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
    Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
    J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia.
    Pascual-Guardia S; Amati F; Marin-Corral J; Aliberti S; Gea J; Soni NJ; Rodriguez A; Sibila O; Sanz F; Sotgiu G; Marcos PJ; Uranga A; Milenkovic B; Meyer CN; Kolditz M; Anzueto AR; Restrepo MI;
    Arch Bronconeumol; 2023 Feb; 59(2):90-100. PubMed ID: 36376121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors.
    Trinh TD; Zasowski EJ; Claeys KC; Lagnf AM; Kidambi S; Davis SL; Rybak MJ
    Diagn Microbiol Infect Dis; 2017 Sep; 89(1):61-66. PubMed ID: 28716451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital.
    Koh SJ; Lee JH
    Korean J Intern Med; 2015 Sep; 30(5):638-47. PubMed ID: 26354058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community Acquired Pseudomonas Aeruginosa Pneumonia in a Young Athlete Man: A Case Report and Literature Review.
    Rahdar HA; Kazemian H; Bimanand L; Shahraki-Zahedani S; Feyisa SG; Taki E; Havaei SA; Karami-Zarandi M
    Infect Disord Drug Targets; 2018; 18(3):249-254. PubMed ID: 29637871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.
    Gallego M; Pomares X; Espasa M; Castañer E; Solé M; Suárez D; Monsó E; Montón C
    BMC Pulm Med; 2014 Jun; 14():103. PubMed ID: 24964956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A score to predict Pseudomonas aeruginosa infection in older patients with community-acquired pneumonia.
    Wijit K; Sonthisombat P; Diewsurin J
    BMC Infect Dis; 2023 Oct; 23(1):700. PubMed ID: 37858082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.